Publications
25
Citations
393
Est. group size
~3
Recurring co-author estimate
Active years
54
Publishing since 1972
Joseph Azar's research centers on how the immune system interacts with tumors, particularly in pancreatic cancer, with additional work on immune-based therapies (like IL-15-based drugs), stem cell models, and disease modeling using lab-grown tissue structures called organoids. His work spans laboratory studies of tumor tissue, early-phase clinical trials, and broader reviews on cancer care and healthcare systems. This research aims to better understand why tumors respond differently to treatment across patients and to identify markers that could guide diagnosis and therapy.
Publication output has grown from essentially none in 2017-2018 to a steady average of about 3 papers per year over the last five years, with a peak of 7 in 2023.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Tumor Immune Microenvironment Differences Associated With Racial Disparities in Pancreatic Cancer
Journal of Surgical Research · 2025
- Translational and oncologic significance of tertiary lymphoid structures in pancreatic adenocarcinoma
Frontiers in Immunology · 2024
- Ovarian cancer in the Arab world: An updated review
Gene Reports · 2024
- Cardiac differentiation is modulated by anti-apoptotic signals in murine embryonic stem cells
World Journal of Stem Cells · 2024
- Flow of Medication Supply and Funds to Examine Access to the Lebanese Healthcare System after the Collapse of the Subsidy System: A Macro to Micro Overview
2023
- Pre-treatment inflamed tumor immune microenvironment is associated with FOLFIRINOX response in pancreatic cancer
Frontiers in Oncology · 2023
- Phase I Trial Characterizing the Pharmacokinetic Profile of N-803, a Chimeric IL-15 Superagonist, in Healthy Volunteers
The Journal of Immunology · 2022
- The Use of Stem Cell-Derived Organoids in Disease Modeling: An Update
International Journal of Molecular Sciences · 2021
- Tumor Microenvironment in Prostate Cancer: Toward Identification of Novel Molecular Biomarkers for Diagnosis, Prognosis, and Therapy Development
Frontiers in Genetics · 2021
- Modeling Adipogenesis: Current and Future Perspective
Cells · 2020
- Cancerona: Challenges of Cancer Management in Times of COVID-19 Pandemic
SN Comprehensive Clinical Medicine · 2020
- Phase I trial characterizing the pharmacokinetic profile and NK and CD8<sup>+</sup> t cell expansion with n-803, a chimeric IL-15 superagonist, in healthy volunteers.
Journal of Clinical Oncology · 2020
- HTR-8/SVneo: A model for epithelial to mesenchymal transition in the human placenta
Placenta · 2019
- The Journal of Immunology×2
- International Journal of Molecular Sciences×1
- Frontiers in Genetics×1
- Cells×1
- Placenta×1
- Scott A. Hammond
Medicine · The Ohio State University
- Andrew J. Gunderson
Medicine · The Ohio State University
- Yoshinobu Koguchi
Medicine · The Ohio State University
- Tarah J. Ballinger
Medicine · Indiana University
- No‐Joon Song
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile